When was Trinean founded?

Trinean was founded in 2006 and raised its 1st funding round 2 years after it was founded.

Where is Trinean located?

Trinean is headquartered in Gentbrugge, Belgium.

How many employees does Trinean have?

As of Jul 31, 2026, the latest employee count at Trinean is 2.

Is Trinean a funded company?

Trinean is a funded company, having raised a total of $9.45M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Oct 17, 2008.

When was the latest funding round of Trinean?

Trinean's latest funding was a $***** Grant (prize money) round on Jan 01, 2015, with participation from 1 investor.

Where does Trinean rank among its competitors?

Trinean ranks 21st amongst 66 active competitors, of which 14 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Rigaku, which secured $720M in Aug, 2026.

Who are the top competitors of Trinean?

Trinean's top competitors include Rigaku, Impedimed and Magritek. Among them, Rigaku secured the most recent funding round in August, 2026.

Trinean - 2026 Company Profile, Team, Funding & Competitors

Company Details

Trinean develops UV/ VIS spectrometry solutions. Its products include DropSense96, a spectrophotometer used in UV-VIS spectral analysis of microliter droplets of DNA/RNA, protein, and Xpose™ 'Touch & Go' reader, a micro-volume spectrometer improving for DNA/RNA and protein quantification. In addition, the company also provides spectral content profiling software, to be used in conjunction with its devices.

Website: trinean.com
Social

Key Metrics

Founded Year

2006

Location

Gentbrugge, Belgium

Stage

Acqui-Hired

Total Funding

$9.45M in 4 rounds

Latest Funding Round

Grant (prize money), Jan 01, 2015, $*****

Investors

Capricorn Partners & 5 more

Ranked

21^st among 66 active competitors

Employee Count

2 as on Jul 31, 2026

Similar Companies

Rigaku & 75 more

View Trinean's full profile

Trinean has raised a total funding of $9.45M over 4 rounds. Its first funding round was on Oct 17, 2008. Its latest funding round was a Grant (prize money) round on Jan 01, 2015 for $*****. 1 investor participated in its latest round. Trinean has 6 institutional investors.

Here is the list of recent funding rounds of Trinean:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 01, 2015	1392974	Grant (prize money)	7650659	4607600	5308002	9289429
May 30, 2013	8473700	Series A	3130786	7065723	2633977	Capricorn Partners
Apr 27, 2012	9026027	Series A	3661004	9040601	9005294	Vesalius Biocapital Partners & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Trinean's funding rounds and investors

The founders of Trinean is Ronny Bockstaele.

Here are the details of Trinean's key team members:

Ronny Bockstaele: Co-Founder and CTO of Trinean.
Philippe Stas: Co-Founder of Trinean.
Contact Info: 1 email address

View details of Trinean's Founder profiles and Board Members

Trinean's employee count trend

Trinean has 2 employees as of Jul 26. Here is Trinean's employee count trend over the years:

Uncover Trinean's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Trinean include Rigaku, Impedimed and Magritek. Here is the list of Top 10 competitors of Trinean, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Rigaku 1951, Tokyo (Japan), Acquired	Provider of XRD, XRF, SAXS, Raman, metrology and crystallography solutions	$720M	Thecarlylegroup.fr, Onto Innovation & 2 others	56/100
2nd	Impedimed 1999, Carlsbad (United States), Public	Developer of technologies for non-invasive clinical assessment and monitoring of fluid status	$3.44M	Versant Ventures, Starfish Ventures	50/100
3rd	Magritek 2004, Wellington (New Zealand), Series B	Provider of NMR and MRI solutions for industries and research laboratories	-	Pea Green, Ampersand Capital & 30 others	49/100
4th	High Q Technologies 2013, Waterloo (Canada), Seed	Developer of quantum-enabled electron paramagnetic resonance systems for protein analysis	$10.3M	Government of Canada	47/100
5th	Speclipse 2015, Seongnam-si (South Korea), Acquired	Provider of molecular spectroscopy systems for early-stage skin cancer detection	$10.6M	SBVA, InterVest & 11 others	46/100
6th	Kratos 1895, Manchester (United Kingdom), Funding Raised	Analytical instruments based on x-ray photo-electron spectrometry	-	Europa	43/100
7th	Ocean Optics 1992, Orlando (United States), Acquired	Manufacturer of spectrometers and optical sensors	-	Europa	42/100
8th	Spectra Analysis 2004, Boston (United States), Acquired	Provider of infrared spectroscopic instruments for molecular analysis	$9.25M	NMT Capital, MassVentures & 1 others	42/100
9th	Anvajo 2016, Dresden (Germany), Series A	Provider of point-of-care solutions for laboratory diagnostics	$17.3M	Think.Health, Seedcamp & 22 others	41/100
10th	Ahura Scientific 2002, Wilmington (United States), Acquired	Developer of optical systems to identify solid and liquid chemicals	$17M	Arch Venture Partners, Castile Ventures & 3 others	39/100
21st	Trinean 2006, Gentbrugge (Belgium), Acqui-Hired	UV/VIS spectrometry solutions	$9.45M	Capricorn Partners, Capital-E & 4 others	30/100